The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Progesterone Regulates Transcription of the p21 Cyclindependent Kinase Inhibitor Gene through Sp1 and CBP/p300
Open accessAbstract
Progesterone has biphasic effects on proliferation of breast cancer cells; it stimulates growth in the first cell cycle, then arrests cells at G1/S of the second cycle accompanied by up-regulation of the cyclin-dependent kinase inhibitor, p21. We now show that progesterone regulates transcription of the p21 promoter by an unusual mechanism. This promoter lacks a canonical progesterone response element. Instead, progesterone receptors (PRs) interact with the promoter through the transcription factor Sp1 at the third and fourth of six Sp1 binding sites located downstream of nucleotide 154. Mutation of Sp1 site 3 eliminates basal transcription, and mutation of sites 3 and 4 eliminates transcriptional up-regulation by progesterone. Progesterone-mediated transcription is further prevented by overexpression of E1A, suggesting that CBP/p300 is required. Indeed, in HeLa cells, Sp1 and CBP/p300 associate with stably integrated flag-tagged PRs in a multiprotein complex. Since many signals converge on p21, cross-talk between PRs and other factors co-localized on the p21 promoter, may explain how progesterone can be either proliferative or differentiative in different target cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O'Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., & Freedman, L. P. (1996) · Genes & Development · doi:10.1101/gad.10.2.142 · Cited by 890
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650
Transcription from a TATA-less promoter requires a multisubunit TFIID complex.
Pugh, B. F., & Tjian, R. (1991) · Genes & Development · doi:10.1101/gad.5.11.1935 · Cited by 595
Gill, G., Pascal, E., Tseng, Z. H., & Tjian, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.192 · Cited by 531
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
Somasundaram, K., Zhang, H., Zeng, Y.-X., Houvras, Y., Peng, Y., Zhang, H., Wu, G. S., Licht, J. D., Weber, B. L., & El-Deiry, W. S. (1997) · Nature · doi:10.1038/38291 · Cited by 509
Induction of p21 (WAF-1/CIP1) during differentiation.
Steinman, R. A., Hoffman‐Liebermann, B., Iro, A., Guillouf, C., Liebermann, D. A., & El-Houseini, M. E. (1994) · PubMed · Cited by 477
Datto, M. B., Yu, Y., & Wang, X.-F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28623 · Cited by 434
Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor
Porter, W. W., Saville, B., Hoivik, D. J., & Safe, S. H. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1569 · Cited by 428
Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22199 · Cited by 395
Janknecht, R., & Hunter, T. (1996) · Nature · doi:10.1038/383022a0 · Cited by 393
Sartorius, C. A. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1347 · Cited by 342
Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M., & Dotto, G. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5451 · Cited by 328
Slansky, J. E., Li, Y., Kaelin, W. G., & Farnham, P. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1610 · Cited by 311
Transcriptional Activation of the Human p21 Gene by Retinoic Acid Receptor
Liu, M., Iavarone, A., & Freedman, L. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31723 · Cited by 301
Groshong, S. D., Owen, G. I., Grimison, B., Schauer, I. E., Todd, M. C., Langan, T. A., Sclafani, R. A., Lange, C. A., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1593 · Cited by 299
Self-citationp300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
Puri, P. L. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.369 · Cited by 284
HORWITZ, K. B. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-146 · Cited by 221
Self-citationSartorius, C. A., Groshong, S. D., Miller, L. A., Powell, R. L., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1994) · PubMed · Cited by 212
Self-citationBiggs, J. R., Kudlow, J. E., & Kraft, A. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.901 · Cited by 210
Wood, W. M., Kao, M. Y., Gordon, D. F., & Ridgway, E. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63777-9 · Cited by 198
Matsumura, I., Ishikawa, J., Nakajima, K., Oritani, K., Tomiyama, Y., Miyagawa, J.-I., Kato, T., Miyazaki, H., Matsuzawa, Y., & Kanakura, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2933 · Cited by 190
Musgrove, E. A., Lee, C. S., & Sutherland, R. L. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5032 · Cited by 175
Estes, P. A., Suba, E. J., Lawler-Heavner, J., El‐Ashry, D., Wei, L. L., Toft, D. O., Sullivan, W. P., Horwitz, K. B., & Edwards, D. P. (1987) · Biochemistry · doi:10.1021/bi00393a045 · Cited by 157
Self-citationProgestin Action and Progesterone Receptor Structure in Human Breast Cancer: A Review
Horwitz, K. B., Wei, L. L., SEDLACEK, S. M., & d'Arville, C. N. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-571141-8.50010-x · Cited by 136
Self-citationInvolvement of the Sp3 Transcription Factor in Induction of p21 in Keratinocyte Differentiation
Prowse, D. M., Bolgan, L., Molnár, À., & Dotto, G. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1308 · Cited by 130
Datto, M., Hu, P. P.-C., Kowalik, T. F., Yingling, J. M., & Wang, X. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2030 · Cited by 99
Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells.
Bamberger, A., Bamberger, C. M., Gellersen, B., & Schulte, H. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6169 · Cited by 97
Athanikar, J. N., Sanchez, H. B., & Osborne, T. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5193 · Cited by 88
Musgrove, E. A., Lee, C. S. L., Cornish, A. L., Swarbrick, A., & Sutherland, R. L. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.1.9869 · Cited by 74
Horwitz, K. B., Pike, A. W., Gonzalez-Aller, C., & Fennessey, P. V. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90323-7 · Cited by 29
Self-citation
Cited by
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Transcriptional Regulation of the p21(WAF1/CIP1)Gene
Gartel, A. L., & Tyner, A. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4319 · Cited by 664
Decidualization of the Human Endometrium: Mechanisms, Functions, and Clinical Perspectives
Gellersen, B., Brosens, I., & Brosens, J. (2007) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-991042 · Cited by 587
Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases
Robker, R. L., Russell, D. L., Espey, L. L., Lydon, J. P., O'Malley, B. W., & Richards, J. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080073497 · Cited by 544
Metadata
- Authors
- Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., & Horwitz, K. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-04
- Volume
- 273
- Issue
- 17
- Pages
- 10696-10701
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096654038
- Cited by
- 349
- References
- 37
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.